1-4 of 4
Ningying Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Waning Long Term Efficacy of COVID-19 Post-Transplant Vaccination for Prevention of COVID-19 Adverse Events in Transplant and Cellular Therapy (TCT) Patients

Rahul Ramaswamy, Laith Fakhoury, Peter Zhao, Ningying Wu, Feng Gao, Geoffrey L. Uy, John F. DiPersio, Zachary D. Crees
Journal: Blood
Blood (2024) 144 (Supplement 1): 3532.
https://doi.org/10.1182/blood-2024-204417
Published: 2024
Journal Articles

Phase II Trial of Duvelisib Maintenance after Autologous Stem Cell Transplant in T-Cell and B-Cell Non-Hodgkin Lymphomas: Results of Safety Lead in

Raya Saba, Neha Mehta-Shah, Armin Ghobadi, John F. DiPersio, Amanda F Cashen, Ningying Wu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6245.
https://doi.org/10.1182/blood-2023-174109
Published: 2023
Journal Articles

Outcomes of Patients with Baseline Marrow Fibrosis at Allogeneic Hematopoietic Cell Transplantation

Pavan Kumar Bhamidipati, MBBS, MD, Han Se-Young, MD, Shivaprasad Manjappa, MD, Ningying Wu, PhD, Ravi Vij, MDMBA, Amanda F. Cashen, MD, John F DiPersio, MD PhD, Camille N. Abboud, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3204.
https://doi.org/10.1182/blood.V130.Suppl_1.3204.3204
Published: 2017
Journal Articles

A Phase II Study Of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) As Conditioning Regimen Prior To Second Autologous Stem Cell Transplantation For Multiple Myeloma

Tzu-Fei Wang, MD, Mark A. Fiala, BS, CCRP, Ningying Wu, PhD, Theresa Fletcher, Camille N. Abboud, MD, Amanda F. Cashen, MD, John F. Dipersio, MD, PhD, Geoffrey L. Uy, MD, Peter Westervelt, MD, PhD, Keith E. Stockerl-Goldstein, MD, Ravi Vij, MD
Journal: Blood
Blood (2013) 122 (21): 5492.
https://doi.org/10.1182/blood.V122.21.5492.5492
Published: 2013